Overview
- Researchers engineered hollow graphitic carbon nitride nanoparticles about 300 nanometers wide that act as microscopic light transducers by producing local photoelectrochemical and photothermal effects.
- When injected into eyes with advanced retinal degeneration, the particles settled near retinal ganglion cells and produced light-evoked electrical activity in the visual cortex along with measurable behavioral responses in blind mice.
- Ex vivo tests on porcine retinal tissue showed the same particles can directly trigger retinal ganglion cell firing under LED stimulation, supporting cross-species preclinical efficacy.
- The team has filed international patents and is now focusing on long-term ocular biocompatibility, delivery methods, functional durability, and safety studies before any human trials can begin.
- Unlike mutation-specific gene therapies, optogenetics, or surgically implanted electronic prostheses, this approach uses surviving retinal neurons as a wireless interface, but it currently restores light sensitivity rather than normal high-acuity vision.